{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:36:26Z","timestamp":1783082186032,"version":"3.54.6"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.eimc.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T18:05:36Z","timestamp":1522951536000},"page":"648-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vacunaci\u00f3n frente a tuberculosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Carlos","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacho","family":"Aguilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Gonzalo-Asensio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2018.02.006_bib0255","series-title":"WHO Global Tuberculosis Report 2017","first-page":"1","year":"2017"},{"key":"10.1016\/j.eimc.2018.02.006_bib0260","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2018.02.006_bib0265","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: A database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.eimc.2018.02.006_bib0270","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.eimc.2018.02.006_bib0275","doi-asserted-by":"crossref","unstructured":"Gheorghiu M, Lagranderie M, Balazuc A-M. Tuberculosis and BCG. En: Artenstein AW, editor. Vaccines: A Biography New York, NY: Springer; 2009. p. 16.","DOI":"10.1007\/978-1-4419-1108-7_8"},{"key":"10.1016\/j.eimc.2018.02.006_bib0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0285","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.vaccine.2010.07.086","article-title":"WHO informal consultation on standardization and evaluation of BCG vaccines Geneva Switzerland 22-23 September 2009","volume":"28","author":"Ho","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2018.02.006_bib0290","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol Ther."},{"key":"10.1016\/j.eimc.2018.02.006_bib0295","unstructured":"Lambach DP. WHO informative sheet BCG. 2012 June, pp. 1-5."},{"key":"10.1016\/j.eimc.2018.02.006_bib0300","series-title":"Pediatric Vaccines and Vaccinations","first-page":"149","article-title":"Tuberculosis Vaccines","author":"Martin\u00f3n-Torres","year":"2017"},{"key":"10.1016\/j.eimc.2018.02.006_bib0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vaccine.2014.04.084","article-title":"Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults","volume":"32","author":"Hatherill","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2018.02.006_bib0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Gu\u00e9rin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.eimc.2018.02.006_bib0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2018.02.006_bib0320","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/cid\/cit793","article-title":"Understanding BCG is the key to improving it","volume":"58","author":"Mcshane","year":"2014","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ije\/dyx141","article-title":"The duration of protection of school-aged BCG vaccination in England: A population-based case\u2014control study","volume":"47","author":"Mangtani","year":"2018","journal-title":"Int J Epidemiol."},{"key":"10.1016\/j.eimc.2018.02.006_bib0330","first-page":"3759","volume":"Vaccine","author":"Barreto","year":"2014","journal-title":"Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses"},{"key":"10.1016\/j.eimc.2018.02.006_bib0335","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cid\/cix340","article-title":"Beneficial non-specific effects of oral polio vaccine (OPV): Implications for the cessation of OPV?","volume":"65","author":"Aaby","year":"2017","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0340","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ebiom.2016.07.016","article-title":"Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall survival: A review","volume":"10","author":"Benn","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.eimc.2018.02.006_bib0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab \u2014 a big effect: Nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.eimc.2018.02.006_bib0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"De Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2018.02.006_bib0355","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/cid\/civ148","article-title":"Editorial commentary: Nonspecific beneficial effects of BCG vaccination in high-income countries should we extend recommendation of BCG vaccination?","volume":"60","author":"Iglesias","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0360","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eimc.2018.02.006_bib0365","doi-asserted-by":"crossref","first-page":"17317","DOI":"10.1073\/pnas.1215761109","article-title":"Saving lives by training innate immunity with bacille Calmette-Guerin vaccine","volume":"109","author":"Aaby","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.eimc.2018.02.006_bib0370","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"A memory for innate host defense cell host microbe","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.eimc.2018.02.006_bib0375","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.eimc.2018.02.006_bib0380","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Reports."},{"key":"10.1016\/j.eimc.2018.02.006_bib0385","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1586\/14760584.2013.856765","article-title":"Recent developments in tuberculosis vaccines","volume":"12","author":"Marinova","year":"2013","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.eimc.2018.02.006_bib0390","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3389\/fimmu.2017.01203","article-title":"TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.eimc.2018.02.006_bib0395","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10124","article-title":"A 2020 vision for vaccines against HIV, tuberculosis and malaria","volume":"473","author":"Rappuoli","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.eimc.2018.02.006_bib0400","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2018.02.006_bib0405","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: An observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.eimc.2018.02.006_bib0410","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(15)00499-5","article-title":"The transmission of Mycobacterium tuberculosis in high burden settings","volume":"16","author":"Yates","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0415","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.epidem.2015.10.001","article-title":"Tuberculosis in Cape Town: An age-structured transmission model","volume":"14","author":"Blaser","year":"2016","journal-title":"Epidemics."},{"key":"10.1016\/j.eimc.2018.02.006_bib0420","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.7717\/peerj.1513","article-title":"On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines","volume":"4","author":"Arregui","year":"2016","journal-title":"Peer J."},{"key":"10.1016\/j.eimc.2018.02.006_bib0425","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3389\/fmicb.2016.01536","article-title":"The progress of therapeutic vaccination with regard to tuberculosis","volume":"7","author":"Cardona","year":"2016","journal-title":"Front Microbiol."},{"key":"10.1016\/j.eimc.2018.02.006_bib0430","doi-asserted-by":"crossref","first-page":"e89612","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: Randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS ONE."},{"issue":"Suppl. 1","key":"10.1016\/j.eimc.2018.02.006_bib0435","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.tube.2016.05.013","article-title":"TB vaccines in clinical development","volume":"99","author":"Ginsberg","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.eimc.2018.02.006_bib0440","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/jiw228","article-title":"Vaccination against tuberculosis with whole-cell Mycobacterial vaccines","volume":"214","author":"Scriba","year":"2016","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0445","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille Calmette-Gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.eimc.2018.02.006_bib0450","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/cir951","article-title":"Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis","volume":"54","author":"Andrews","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2018.02.006_bib0455","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: The Geneva consensus on essential steps towards clinical development","volume":"29","author":"Kamath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2018.02.006_bib0460","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva Consensus: Recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2018.02.006_bib0465","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1038\/ncomms16085","article-title":"Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis","volume":"8","author":"Aguilo","year":"2017","journal-title":"Nat Commun."},{"key":"10.1016\/j.eimc.2018.02.006_bib0470","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14760584.2017.1324303","article-title":"MTBVAC from discovery to clinical trials in tuberculosis-endemic countries","volume":"16","author":"Marinova","year":"2017","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.eimc.2018.02.006_bib0475","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2015.10.010","article-title":"MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice","volume":"96","author":"Aguilo","year":"2016","journal-title":"Tuberculosis (Edinb.)."},{"key":"10.1016\/j.eimc.2018.02.006_bib0480","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbu\u00e9s","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2018.02.006_bib0485","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: A randomised, double-blind, controlled phase I trial","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.eimc.2018.02.006_bib0490","doi-asserted-by":"crossref","first-page":"e1004183","DOI":"10.1371\/journal.ppat.1004183","article-title":"The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis","volume":"10","author":"Solans","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.eimc.2018.02.006_bib0495","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tube.2015.07.001","article-title":"A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents","volume":"95","author":"Carpenter","year":"2015","journal-title":"Tuberculosis (Edinb.)."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X18300557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X18300557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T01:14:43Z","timestamp":1571015683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X18300557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0213005X18300557"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2018.02.006","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vacunaci\u00f3n frente a tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}